Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

EfficientNet improves accuracy in diagnosing hair loss stages.

This study found that using body hair along with scalp hair in hair transplantation can significantly increase visual density and improve coverage in patients with higher grades of androgenetic alopecia.

This study introduced and evaluated Ahmad's NPRT system for documenting hair loss, finding it helpful in assessing the specific state of male pattern baldness in 500 patients.

This article proposes enhancing the Norwood-Hamilton scale for assessing hair loss patterns but reports no new clinical results.

In this report, the authors suggest that for extensive baldness, the uniform density approach in hair restoration surgery is less noticeable, especially in situations like wind or exercise.

In this study, a daily low-dose regimen of oral minoxidil and finasteride over 12 months led to significant hair density improvements in over 92% of adult men with androgenetic alopecia, including those with advanced stages, though inter-rater reliability in photo assessments was modest.

This study found that using a specific ratio method based on the patient's scalp measurements can effectively predict the dimensions of the permanent safe zone for hair transplants, particularly in early stages of androgenetic alopecia, potentially ensuring long-lasting transplant results.

Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.

The robotic system for hair restoration surgery works well, giving similar results to manual techniques after 9 months.

Hair transplantation is a surgical procedure to move hair to bald areas, requires good donor hair, and results show in about a year.

PRP treatment showed no hair regrowth improvement after the first application in patients with alopecia.

This study found that androgenetic alopecia is significantly associated with an increased risk of Metabolic Syndrome, particularly in early-onset male cases and females exhibiting severe AGA.

This study found that a high proportion of androgenetic alopecia patients were young individuals with mild types, potentially due to psychological stress in social situations.

This study suggests that traditional classification systems for pattern hair loss, while useful in the past, have limitations in accuracy and reproducibility, and highlights the potential of integrating digital imaging and AI to create more precise and biologically informed classification frameworks.

This article reviews various diagnostic tools for hair disorders, describing methods ranging from invasive to noninvasive, but reports no new research findings or clinical results.

This study found that the parietal/occipital hair density ratio decreases significantly only when baldness is visibly present, making it no better than the Hamilton/Norwood scale for assessing baldness severity.

In this study, balding men reported an average willingness to pay around $30,000 to transition from complete baldness to having a full head of hair.

This review identified various outcome measure instruments for assessing androgenetic alopecia but found inconsistent application across clinical trials, underscoring the need for standardized assessment methods.

This study found that patients with androgenetic alopecia had significantly higher COVID-19 severity compared to matched controls, suggesting a potential link between androgen pathways and disease severity. The authors suggest further research to validate this hypothesis and explore antiandrogen treatments for managing COVID-19 severity.

This study found that sub-dermal platelet-rich plasma injections were effective for treating androgenic alopecia among both male and female participants.

This study found that platelet-rich plasma injections significantly increased hair count and improved hair loss in patients with androgenic alopecia, with high patient satisfaction and no notable adverse effects.

This study suggests that a high frequency of androgenetic alopecia is associated with increased severity of COVID-19 in hospitalized patients.

This study observed that one-third of men with early-onset androgenetic alopecia had altered hormonal profiles, which were associated with increased insulin resistance and more severe hair loss.

This study found that men with early-onset male pattern alopecia did not significantly differ from healthy individuals in cardiovascular and metabolic measures, but hsCRP and galectin-3 were linked to cardiovascular risk factors in those with the condition.

This study compares datasets to analyze the prevalence of androgenetic alopecia in patients admitted with severe COVID-19 in three Madrid hospitals, focusing on age, gender, and alopecia severity.

This study reports that a majority of patients hospitalized with severe COVID-19 in three Madrid hospitals exhibited androgenetic alopecia, termed the "Gabrin Sign".

This study found that a genetic test using 5 to 20 SNPs can predict male pattern baldness with variable accuracy in European men, especially those aged 50 and older.

This study found that the scalp coverage scoring (SCS) method is a non-invasive and reproducible technique that effectively measures hair growth and loss dynamics in male subjects with androgenetic alopecia.

This study concluded that visits to emergency and urgent care centers for severe sunburn treatment are largely avoidable and contribute to significant healthcare costs.

In this study, Taiwanese men with androgenetic alopecia who took 1 mg/day of finasteride for a year experienced slowed hair loss progression and increased hair growth, with minimal adverse effects reported.